This company has been marked as potentially delisted and may not be actively trading. NYSE:PBY Prospect Capital (PBY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Prospect Capital Stock (NYSE:PBY) Get Prospect Capital alerts:Sign Up Key Stats Today's Range$25.00▼$25.1050-Day Range$25.00▼$26.1352-Week Range$23.06▼$26.75Volume10,450 shsAverage Volume4,181 shsMarket Capitalization$1.35 billionP/E RatioN/ADividend Yield6.24%Price TargetN/AConsensus RatingN/A Company Overview Read More Receive PBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prospect Capital and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBY Stock News HeadlinesProspect Capital CEO buys $1.02M in common stockSeptember 25, 2025 | msn.comProspect Capital CEO buys $1.02M of stockSeptember 25, 2025 | msn.comIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.October 16 at 2:00 AM | Huge Alerts (Ad)Why Is Prospect Capital (PSEC) Stock Soaring TodaySeptember 25, 2025 | msn.comProspect Capital And Thesis Capital Partners Invests $18 Million in The RidgeSeptember 15, 2025 | msn.comProspect Capital Corporation and Affiliate Complete $18 Million Investment in The RidgeSeptember 8, 2025 | markets.businessinsider.comProspect Capital signals continued portfolio shift to 70.5% first lien loans while exiting real estate assetsAugust 27, 2025 | msn.comProspect Capital options imply 8.3% move in share price post-earningsAugust 26, 2025 | msn.comSee More Headlines PBY Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Prospect Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prospect Capital investors own include AGNC Investment (AGNC), PepsiCo (PEP), AutoNation (AN), Garmin (GRMN), CVS Health (CVS), Energy Transfer (ET) and Hercules Capital (HTGC). Industry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Auto Parts Stores Sub-IndustryAutomotive Retail Current SymbolNYSE:PBY CIK77449 Webwww.pepboys.com PhoneN/AFaxN/AEmployeesN/AYear Founded2004Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares54,020,000Free FloatN/AMarket Cap$1.35 billion OptionableNot Optionable BetaN/A Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:PBY) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prospect Capital Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prospect Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
